Dangerous products are those that can cause injury or illness. So is it a stretch to believe that even the precursors to the controlled substance methamphetamine should be well regulated? The U.S. government believes so.
CVS/Pharmacy will pay a record $75 million to settle a case brought by federal prosecutors accusing the drugstore giant of not doing enough to safeguard the sale of cold medicines used to produce methamphetamine. According to prosecutors, CVS failed to properly regulate the sales of cold medicine containing pseudoephedrine, an ingredient used in the making of methamphetamine. Prosecutors alleged this oversight helped to fuel the meth trade in California and other states.
That’s the Associated Press’s rundown of the situation. CVS is reportedly paying up to $75 million in fines regarding the sale. Reportedly, “thousands” of violations were found in Los Angeles County, Orange County and Clark County in Nevada. In addition to the main issue of attempting to make it more difficult to produce a dangerous drug, there are other reasons to find this good news. Methamphetamine producers operate in very dangerous environments, and mishandling the materials can lead to explosions in residential areas that harm others. More importantly, the advent of a portable “shake and bake” method that can be completed in a car trunk means that efforts to limit the acquisition of ingredients could mean lower auto accidents in California.